On the forefront of transformation: Genomic applications in oncology

On the forefront of transformation: Genomic applications in oncology

Topic: Cancer Genomics

The emergence of next-generation sequencing (NGS) and extensive collaboration with the cancer community have made possible a new understanding of the genes and pathways that drive tumor growth. These advances help propel targeted pharmaceutical development and bring us closer to the realization of precision medicine. As a leader in NGS technology, Illumina is investing in the development of novel clinical oncology solutions. Join our Medical Affairs leadership team to learn about the basic principles of next-generation sequencing. Explore the applications of genomics in oncology for germline risk prediction and precision medicine, including how NGS demonstrates the importance of circulating nucleic acids for molecular monitoring.



There are no related events.